Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDURSULFASE vs IMATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IDURSULFASE vs IMATINIB: Safety Overview

Metric IDURSULFASE IMATINIB
Total FAERS Reports 3,188 43,161
Deaths Reported 526 13,761
Death Rate 16.5% 31.9%
Hospitalizations 1,734 7,264
Average Patient Age 13.2 yrs 55.7 yrs
% Female Patients 1.1% 47.2%
FDA Approval Date N/A Apr 14, 2025
Manufacturer Takeda Pharmaceuticals America, Inc. Dr.Reddy's Laboratories Inc
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued